Tedizolid phosphate Pharma Grade
856867-55-5
Pharmaceutical Grade
SHANGHAI
1kg/0.12kg Bag
2017-06-29
CAL-101 Tedizolid Afatinib Nintedanib Lenvatinib,Neratinib Olaparib Rucaparib and intermediates
-
Product Description
-
Seller Information
-
Description
Chemical Information
Product name: Tedizolid phosphate
Synonyms: TR 701FA; (5R)-3-[3-Fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]-5-[(phosphonooxy)methyl]-2-oxazolidinone
CAS No.: 856867-55-5
Molecular Formula: C17H16FN6O6P
Molecular weight: 450.32
Technicel Data
Appearance: Tech pack
purity: 99.8%min
Solubility: DMSO
Package: Packaging according to customer requirements
Storage: −20°C 2 years
Shipping condition: Conventional transport
http://www.shinningpharm.com/products_detail_e/id/16.html
Basic Info-
Product Name:
Tedizolid phosphate
Other Name:2-Oxazolidinone,3-[3-fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]-5-[(phosphonooxy)methyl]-,(5R)-;(5R)-3-[3-Fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]-5-[(phosphonooxy)methyl]-2-oxazolidinone;TR 701FA;Tedizolid phosphate;Tedizolid hydrogen phosphate
CAS No.:856867-55-5
Molecular Formula:C17H16FN6O6P
InChIKeys:InChIKey=QCGUSIANLFXSGE-GFCCVEGCSA-N
Molecular Weight:468.3329842
Exact Mass:450.32
UNII:O7DRJ6R4DW
DSSTox ID:DTXSID30234977
ATC Code:J01XX11
Categories:
Characteristics-
PSA:
153
XLogP3:0.3
Density:1.8±0.1 g/cm3
Flash Point:392.6±35.7 °C
Refractive Index:1.739
Hazard IdentificationClassification of the substance or mixture
Reproductive toxicity, Category 2
Specific target organ toxicity â repeated exposure, Category 2
Hazardous to the aquatic environment, short-term (Acute) - Category Acute 1
Hazardous to the aquatic environment, long-term (Chronic) - Category Chronic 1
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H361 Suspected of damaging fertility or the unborn child
H373 May cause damage to organs through prolonged or repeated exposure
H400 Very toxic to aquatic life
H410 Very toxic to aquatic life with long lasting effects
Precautionary statement(s) Prevention P203 Obtain, read and follow all safety instructions before use.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P260 Do not breathe dust/fume/gas/mist/vapours/spray.
P273 Avoid release to the environment.
Response P318 IF exposed or concerned, get medical advice.
P319 Get medical help if you feel unwell.
P391 Collect spillage.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
CAL-101 Tedizolid Afatinib Nintedanib Lenvatinib,Neratinib Olaparib Rucaparib and intermediates
-
Location:
Ningyang Fine Chemicial Industry Park , Tai'an, Shandong.
-
Payment Terms:
L/C,D/A
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
51-100
Shandong Shining Pharm Co., Ltd. is Investment and holding by a natural person, sets up three R&D Centers under Shining Pharm: Jinan Synovel Laboratory Co., Ltd., Tianjin Chemlike Scientific Co., Ltd. and Nanjing Leizheng Pharm Co., Ltd. Export agent: Taizhou Crene Biotechnology Co., Ltd. Our manufactory Located in Ningyang Fine Chemical Industry Park, Tai’an ,Shangdong province.
Shandong Shining Pharm is a high-tech manufactory, which is committed to producing high quality pharmaceutical intermediates, promoting innovation in API technology and provide customized services for global pharmaceutical companies, dedicates itself on research, develop and industrialize of high-end intermediates & API. We have three R&D centers from Ji’nan, Tianjin and Nanjing, more than 40 R&D staff including 5 doctors, 20 masters and 18 synthesis assistants, along with their unique advantages in the product development, pilot and process optimization, of total hundred employees. Our products are highly praised by global customers as we are Closed cooperation with domestic pharmaceutical companies, with International market of
Shandong Shining Pharm Covers an area of 40 mu (around 30000 square meter), located at Ningyang Fine Chemical Industry Park, Tai’an., which is a provincial chemical industry park, It is a high standard manufactory and about to set up cGMP quality system. Our plant including 500㎡ analysis laboratories equipped with HPLC, LC-MS, GC and other analytical facilities, one pilot and four mass production workshop, the total reaction capacity can reach 35000L which can meet commercial production demands from kilos to hundreds of tons, is perfect for analysis and production.
Shandong Shining Pharm provides the high-level products and the most reasonable price for our Partners. Our main products of intermediates: Idelalisib ints, Tedizolid ints, Afatinib ints, Nintedanib ints, Lenvatinib ints Trifluridine（ TAS-102）ints, etc.
“Social commitment, Professional services, Benefits society, Create better life” is Shandong Shining Pharm philosophy, Shandong Shining Pharm sincerely welcome global partners to get win-win cooperation, create a bright future!
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
